NEW DELHI: India's top two stock exchanges have approved the merger of Ranbaxy Lab oratories with Sun Pharmaceutical, clearing at least one regulatory hurdle facing consummation of the country's largest in-bound pharma deal inked four months ago. Times of India, 1 month ago
Sun Pharma - Ranbaxy merger to create US$ 4 billion Indian pharma entity - PharmaBiz, 1 month ago
Stocks in news: Tilaknagar, United Spirits, Ranbaxy, MCF - Money Control, 1 week ago
3 images for "ranbaxy lab"
Akshata Deshmukh, Chief Strategist-Trading at Networth Stock Broking is of the view that one may hold Ranbaxy Laboratories with a target of Rs 750-770.Money Control, 1 week ago Hold Ranbaxy Labs; target of Rs 615: KRChoksey Money Control, 2 weeks ago Buy Ranbaxy Labs; target of Rs 605: Motilal Oswal Money Control, 1 month ago Accumulate Ranbaxy Labs; target of Rs 616: PLilladher Money Control, 1 month ago
With the fresh exits, nearly half of the members who were part of Ranbaxy’s executive committee two years ago will no longer be part of the team. NEW DELHI: Ranbaxy Laboratories' global HR head Sandeep Girotra has stepped down while its president of ...Economic Times, 1 week ago
, ET Bureau | 7 Jun, 2014, 04.27AM IST Post a Comment Ranbaxy reported a net loss ofRs 74 crore in the quarter to March, partly due to write-offs resulting from the suspended production at Toansa following the FDA blacklisting. NEW DELHI: India's drug ...Economic Times, 2 months ago Ranbaxy Labs reduces net loss to Rs.186 crore in Q1 PharmaBiz, 1 month ago Ranbaxy Q1 disappoints, posts loss at Rs 186cr on provision Moneycontrol.com, 1 month ago Avanir Settles With Ranbaxy Over Nuedexta Generic FDA News, 2 months ago
Sun Pharmaceutical Industries, India's largest drugmaker by market value, said it is in the process of acquiring Ranbaxy Lab from Japan's Daiichi Sankyo, and is open for more acquisitions. "Till the time we are able to integrate Ranbaxy ...DNA India, 2 weeks ago Sun's Ranbaxy deal on course, hints at more 4 Traders, 2 weeks ago
Sun Pharma, Ranbaxy, Dr Reddy's Lab, Lupin, Glenmark, Wockhardt and Cadila Healtchare gained 1-8% on BSE.Business Standard, 1 month ago Pharma shares in demand; Aurobindo surges 5% INooz, 1 month ago
Ranbaxy’s subsidiary Ohm Lab has received drug regulator US Food and Drug Administration's nod for generic version of Novartis’ blood pressure drug Diovan.Money Control, 2 months ago Ranbaxy arm Ohm Lab gets USFDA nod for Valsartan Myiris, 2 months ago Ranbaxy gets FDA approval for Novartis's Diovan generic The Financial Chronicle, 2 months ago
Shares of Wockhardt, Dr Reddy's Lab, Cipla and Ranbaxy fell 1.2%, 1.1%, 0.9% and 0.3%, respectively. Photo: AFP Mumbai: Shares of drug makers fell after the pharmaceutical pricing regulator capped the prices of 50 drugs used to treat diabetes and ...Livemint.com, 1 month ago
Ranbaxy Laboratories announced that the ESOPs allotment committee of directors has allotted 207,529 equity shares on exercise of stock options under the Employees Stock Option Scheme(s) of the company. The paid-up equity share capital of the ...MyIris, 1 month ago
A total of 447 stocks touched their 52-week highs on the BSE, including Lupin, Ranbaxy Lab, Strides Arcolab, Sun Pharma, Tata Motors, Tech Mahindra andBusiness Today India, 2 months ago As Sensex flirts with mount 26k, 447 scrips touch 52-week highs Financial Express, 1 month ago Sensex drops after missing 26K by a whisker, outage hits BSE New Delhi Pioneer, 2 months ago Almost 450 stocks hit 52-week highs on BSE ZeeNews.com, 2 months ago
More from: , Money Today...and 1 other sources
on your WebpageAdd Widget >Get your members hooked!